Zenas Biopharma's Purchased 60,000: Insider Buy Deep Dive
A biotech CEO just bought a sizable chunk of his company’s stock. That move sparks questions about conviction, risk, ...
Planning for retirement in your 30s requires understanding key insights. Equip yourself with knowledge to secure a prosperous future.
18,862 articlesA biotech CEO just bought a sizable chunk of his company’s stock. That move sparks questions about conviction, risk, ...
BioCryst faces a pivotal year. This practical guide breaks down what biocryst (bcrx) 2026 earnings could mean for inv...
A recent sale of 25,000 ALHC shares by Alignment Healthcare’s vice chairman has investors wondering about the stock’s...
A five week surge in spot Bitcoin ETF inflows signals renewed institutional interest as hedging flows fade. This arti...
Vertical Aerospace just secured a pivotal supplier contract that could influence its production cadence and investor ...
In 2025, a surprising shift reshaped the starter-home landscape: flippers supplied more starter homes than traditiona...
A bold new era in investing is here. This deep dive explores Jason Wenk’s journey, Altruist’s AI-driven custody model...
A proposed seven-year sell-off rule could alter the economics of build-to-rent projects. This article breaks down wha...
BP plc shares slipped as leadership changes hit the headlines and energy markets swung on oil-price moves. This artic...
The U.S. government is backing quantum startups with billions. Here’s how that move could affect stock selection, ris...
Emerging renders point to a major Siri refresh: a standalone app, deeper Dynamic Island integration, and a Gemini-bas...
When a top executive sells stock, investors ask: Is this a red flag or routine planning? This guide breaks down the 9...